Host cellular transcription and translation machinery

The host cellular transcription and translation machinery is a comprehensive system of enzymes, proteins, and RNA molecules that execute the central dogma of molecular biology: the conversion of DNA into functional proteins (Alberts et al., Molecular Biology of the Cell, 2002). This machinery includes RNA polymerases for transcription in the nucleus, as well as ribosomes, transfer RNAs (tRNAs), and various initiation, elongation, and termination factors for translation in the cytoplasm (Lodish et al., Molecular Cell Biology, 2000). While these processes are fundamental to cellular life, they are frequently exploited by viruses, which hijack the host's ribosomes and factors to produce viral proteins (Nature Reviews Microbiology, 2019). In oncology, the dysregulation of translation initiation—often through the PI3K/AKT/mTOR pathway—is a common driver of tumorigenesis, making specific components like eIF4E or mTOR therapeutic targets (Journal of Clinical Investigation, 2011). However, because this machinery is essential for all cells, drugs that broadly inhibit these processes, such as Actinomycin D or Omacetaxine, often carry significant risks of systemic toxicity and have a narrow therapeutic window (PubChem, 2024). Consequently, therapeutic strategies often focus on specific regulatory nodes rather than the entire machinery to minimize off-target effects on healthy tissues.

Other names

Host cell machineryProtein synthesis apparatusGene expression machineryHost cell biosynthetic pathways

Inhibition of RNA polymerase activity, modulation of translation initiation factors (e.g., eIF4E), and interference with ribosomal translocation or peptide bond formation.